Induction of Apoptosis in Ovarian Carcinoma Cell Line by Gonadotropin-releasing Hormone Agonist

Kurume Medical Journal

Volumn 45, Issue 1, 1998, Pages 27-32

  Motomura, Satoru ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; DNA ladder; Glucocorticoids; GnRH agonist; Ovarian cancer

Indexed keywords

GONADORELIN RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; OVARY TUMOR; PATHOLOGY;

APOPTOSIS; FEMALE; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, LHRH; TUMOR CELLS, CULTURED;

EID: 0031615957     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.45.27     Document Type: Article

References (22)

1. Sevelda P, Vavra N, Fitz R, Barrada M, Salzer H et al. Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancer. Int J Gynecol Cancer 1992; 2:160-162.
2. Wimalasena J, Dostal R, and Meehan D. Gonadotropins, estradiol, and growth factor regulate epithelial ovarian cancer cell growth. Gynecol Oncol 1992; 46:345-350.
3. Kleinman D, Douvdevani A, Schally AV, Levy J, and Sharoni Y. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis. Am J Obstet Gynecol 1994; 170:96-102.
4. Emons G, Orthmann O, Pahwa GS, Hackenberg R, Oberheuser F et al. Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH-agonist in ovarian cancer. Acta Obstet Gynecol Scand 1992; 155:31-38.
5. Parmar H, Rustin G, Lightman SL, Phillips RH, Hanham IW et al. Response to D-Trp-6-luteinising hormone releasing hormone microcapsules in advanced ovarian cancer. Britsh Med J 1988; 296:1229.
6. Eidne KA, Flanagan CA, Harris NS, and Millar RP. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clinical Endocrinology and Metabolism 1987; 64:425-432.
7. Sharoni Y, Bosin E, Miinster A, and Schally AV. Inhibition of growth of human mammary tumorcells by potent antagonists of luteinizing hormone-releasing hormone. Proc Natl Acad Sci 1989; 86:1648-1651.
8. Emons G, Pahwa G, Brack C, Sturm R, Oberheuser F et al. Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata. Eur J Cancer Clin Oncol 1989; 25:211-215.
9. Ohno T, Imai A, Furui T, Takahashi K, and Tamaya T. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma. Am J Obstet Gynecol 1993; 169:605-610.
10. Kataoka A, Nishida T, Motomura S, Higashijima T, Ueyama T et al. The effects of sex steroid hormones, gonadotropin, and gonadotropin releasing hormone agonist on the proliferation of ovarian cancer cell line (KOC-2S). Acta Obst Gynaec Jpn 1994; 46:1033-1040.
11. Billig H, Furuta I, and Hsueh JW. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: Biochemical and insitu detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 1994; 134:245-252.
12. Imai A, Ohno T, Iida K, Fuseya T, Furui T et al. Gonadotorpin-releasing hormone receptor in gynecologic tumors. Cancer 1994; 74:2555-2561.
13. Vilcek J, Palombella VJ, Henriksen-DeStefano D, Swenson C, Feinman R et al. Fibroblast growth-enhancing activity of tumor necrosis factor and its relationhip to other polypeptide growth factors. J Exp Med 1986; 168:187-192.
14. Nagata S, and Golstein P. The Fas death factor. Science 1995; 267:1449-1456.
15. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T et al. Lethal effect of anti-Fas antibody in mice. Nature 1993; 364:806-809.
16. Yonehara S, Ishii A, and Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-1756.
17. Fisher DE. Apoptosis in cancer therapy: Crossing the threshold. Cell 1994; 78:539-542.
18. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267:1445-1449.
19. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
20. Gavrieli Y, Sherman Y, and Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
21. Giunta M, Favre A, Ramarli D, Grossi CE, and Corte G. A novel integrin involved in thymocyte-thymic epithelial cell interactions. J Exp Med 1991; 173:1537-1548.
22. Iwata M, Hanaoka S, and Sato K. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur J Immunol 1991; 21:643-648.